NSC |
Compound |
Enrichment |
Correlation |
NSC 638241 |
Null |
0.00336064452966832 |
0.42849733 |
NSC 639520 |
Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.00336064452966832 |
0.35422784 |
NSC 659390 |
Null |
0.00336064452966832 |
0.42441558 |
NSC 376739 |
5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
0.00356914129105574 |
0.32392898 |
NSC 382034 |
2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- |
0.00356914129105574 |
0.47057342 |
NSC 654509 |
Pirarubicin HCl |
0.00356914129105574 |
0.38907173 |
NSC 670226 |
trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid |
0.00356914129105574 |
0.2750083 |
NSC 673348 |
9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- |
0.00356914129105574 |
0.39431201 |
NSC 692579 |
Null |
0.00356914129105574 |
0.41855992 |
NSC 740 |
Methotrexate |
0.00356914129105577 |
0.50105045 |